Candriam Equities L Biotech.R GBP Acc/ LU1269736911 /
| NAV5/26/2023 | Chg.+1.2200 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 331.3000GBP | +0.37% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016 | - | - | - | 1.78 | 6.34 | -0.22 | 13.38 | -0.98 | 4.89 | -7.09 | 6.69 | -1.70 | - |
| 2017 | 3.68 | 8.06 | -0.33 | -2.25 | -2.67 | 8.77 | 0.96 | 9.35 | -3.03 | -5.59 | -1.71 | 1.60 | +16.63% |
| 2018 | 1.56 | -1.50 | -3.82 | -1.36 | 8.33 | 1.66 | 5.15 | 5.15 | -2.36 | -12.19 | 4.34 | -8.09 | -5.01% |
| 2019 | 9.60 | 2.48 | 1.57 | -4.94 | -1.13 | 8.43 | 1.71 | -1.78 | -5.58 | 5.95 | 12.07 | 0.42 | +30.77% |
| 2020 | -4.75 | 1.68 | -2.07 | 10.52 | 11.77 | 1.40 | -8.64 | -1.09 | 4.37 | -2.62 | 6.07 | 0.63 | +16.46% |
| 2021 | 1.40 | -4.28 | -2.95 | 2.41 | -4.51 | 9.22 | -2.04 | 5.02 | -2.21 | -1.43 | -0.87 | 0.09 | -1.00% |
| 2022 | -9.68 | -1.51 | 8.13 | -2.66 | -4.29 | 7.47 | 4.56 | 6.25 | 2.32 | 3.31 | 2.71 | -3.77 | +11.79% |
| 2023 | 0.61 | -4.02 | -1.78 | 0.66 | 1.51 | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 18.99% | 20.51% | 23.89% | 22.77% | 24.39% |
| Sharpe ratio | -0.59 | -0.42 | 0.63 | -0.02 | 0.22 |
| Best month | +1.14% | +2.71% | +7.47% | +11.77% | +12.07% |
| Worst month | -4.02% | -4.02% | -4.29% | -9.68% | -12.19% |
| Maximum loss | -10.20% | -11.62% | -11.83% | -22.16% | -22.81% |
| Outperformance | -2.38% | - | +0.14% | - | - |
All quotes in GBP
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Biotech.V US... | reinvestment | 1,854.9301 | +14.53% | +7.61% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 202.3000 | +14.80% | - | |
| Candriam Equities L Biotech.I EU... | reinvestment | 1,898.8300 | +11.20% | +0.69% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 2,022.4399 | +14.37% | +10.00% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,158.8201 | +16.81% | +6.35% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 331.3000 | +20.23% | +8.68% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 295.7600 | +15.80% | +11.68% | |
| Candriam Equities L Biotech.R CH... | reinvestment | 189.2600 | +10.66% | +0.77% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 1,656.3400 | +18.51% | - | |
| Candriam Equities L Biotech.I US... | reinvestment | 5,065.0400 | +16.94% | +6.92% | |
| Candriam Equities L Biotech.V US... | reinvestment | 546.5600 | +14.33% | +4.86% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 182.9800 | +11.60% | -0.01% | |
| Candriam Equities L Biotech.R US... | reinvestment | 239.8400 | +18.21% | +8.47% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 189.2000 | +11.89% | +2.37% | |
| Candriam Equities L Biotech.C US... | reinvestment | 764.4200 | +14.81% | +6.30% | |
| Candriam Equities L Biotech.C US... | paying dividend | 702.4000 | +14.77% | +6.19% |
Performance
| YTD | -3.43% | ||
|---|---|---|---|
| 6 Months | -3.08% | ||
| 1 Year | +20.23% | ||
| 3 Years | +8.68% | ||
| 5 Years | +51.18% | ||
| 10 Years | - | ||
| Since start | +120.05% | ||
| Year | |||
| 2022 | +11.79% | ||
| 2021 | -1.00% | ||
| 2020 | +16.46% | ||
| 2019 | +30.77% | ||
| 2018 | -5.01% | ||
| 2017 | +16.63% | ||